Literature DB >> 8565754

Nafcillin-associated hepatotoxicity. Report of a case and review of the literature.

M E Presti1, C G Janney, B A Neuschwander-Tetri.   

Abstract

Nafcillin is a semisynthetic penicillin that is generally well tolerated with few side effects. Hepatic complications are rare but have a potential for serious liver dysfunction. This unusual complication causes a predominantly cholestatic injury, which can persist for prolonged periods even after discontinuing the medication. The pathophysiology may include direct cytotoxicity or an immune-mediate hypersensitivity. Treatment is generally supportive, except for severely symptomatic patients who may require steroids. We report a case of nafcillin-associated hepatotoxicity and review the literature of this disorder.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8565754     DOI: 10.1007/bf02208602

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  23 in total

1.  Oxacillin-associated hepatitis.

Authors:  I Klein; H Tobias
Journal:  Am J Gastroenterol       Date:  1976-06       Impact factor: 10.864

2.  Hepatic injury associated with penicillin therapy.

Authors:  L I Goldstein; K G Ishak
Journal:  Arch Pathol       Date:  1974-08

3.  Hepatic dysfunction following nafcillin and cephalothin therapy in a patient with a history of oxacillin hepatitis.

Authors:  W I Miller; P F Souney; J T Chang
Journal:  Clin Pharm       Date:  1983 Sep-Oct

4.  Flucloxacillin-associated liver damage.

Authors:  S Lobatto; B A Dijkmans; H Mattie; J P Van Hooff
Journal:  Neth J Med       Date:  1982       Impact factor: 1.422

5.  Reversible oxacillin hepatotoxicity.

Authors:  R N Olans; L B Weiner
Journal:  J Pediatr       Date:  1976-11       Impact factor: 4.406

6.  Hepatitis from intravenous high-dose oxacillin therapy: findings in an adult inpatient population.

Authors:  I M Onorato; J L Axelrod
Journal:  Ann Intern Med       Date:  1978-10       Impact factor: 25.391

7.  Atenolol-associated cholestasis.

Authors:  M S Schwartz; M S Frank; A Yanoff; R Morecki
Journal:  Am J Gastroenterol       Date:  1989-09       Impact factor: 10.864

8.  Flucloxacillin-induced cholestatic liver damage.

Authors:  F Bengtsson; C H Florén; I Hägerstrand; C Söderström; T Aberg
Journal:  Scand J Infect Dis       Date:  1985

9.  Cloxacillin-induced cholestatic jaundice.

Authors:  F Konikoff; J Alcalay; J Halevy
Journal:  Am J Gastroenterol       Date:  1986-11       Impact factor: 10.864

10.  Oxacillin hepatitis. Two patients with liver biopsy, and review of the literature.

Authors:  A H Bruckstein; A A Attia
Journal:  Am J Med       Date:  1978-03       Impact factor: 4.965

View more
  4 in total

1.  Tolerability of cefazolin after immune-mediated hypersensitivity reactions to nafcillin in the outpatient setting.

Authors:  Kimberly G Blumenthal; Ilan Youngster; Erica S Shenoy; Aleena Banerji; Sandra B Nelson
Journal:  Antimicrob Agents Chemother       Date:  2014-03-17       Impact factor: 5.191

2.  Drug-induced Liver Injury.

Authors:  Stefan David; James P Hamilton
Journal:  US Gastroenterol Hepatol Rev       Date:  2010-01-01

3.  A fatal case of nafcillin-induced hepatotoxicity: a case report and the literature review.

Authors:  Mian Bilal Alam; Amin Kadoura; Magesh Sathaiah
Journal:  Case Rep Med       Date:  2012-07-11

4.  Nafcillin-Induced Allergic Eosinophilic Cholestatic Hepatitis.

Authors:  Mark V Guido; Warit Jithpratuck; Graham E Parks; Guha Krishnaswamy
Journal:  Gastroenterology Res       Date:  2017-06-30
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.